{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:47:01Z","timestamp":1783032421734,"version":"3.54.6"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T00:00:00Z","timestamp":1441670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jaad.2015.08.040","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T02:04:39Z","timestamp":1445825079000},"page":"1040-1054.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA)"],"prefix":"10.1016","volume":"73","author":[{"given":"Jared","family":"Jagdeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib1","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS (London, England)"},{"issue":"18","key":"10.1016\/j.jaad.2015.08.040_bib2","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS (London, England)"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2015.08.040_bib3","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/00126334-200212153-00011","article-title":"Relationship between HAART adherence and adipose tissue alterations","volume":"31","author":"Ammassari","year":"2002","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"10","key":"10.1016\/j.jaad.2015.08.040_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/09540120801926993","article-title":"Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy","volume":"20","author":"Rajagopalan","year":"2008","journal-title":"AIDS Care"},{"issue":"9","key":"10.1016\/j.jaad.2015.08.040_bib5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS (London, England)"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.040_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/aid.2012.0214","article-title":"High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy","volume":"29","author":"Leclercq","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.040_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/09540120802511851","article-title":"Cost consequences of HIV-associated lipoatrophy","volume":"21","author":"Hornberger","year":"2009","journal-title":"AIDS Care"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archderm.142.3.329","article-title":"Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy","volume":"142","author":"Cattelan","year":"2006","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2015.08.040_bib9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/QAD.0b013e3281c6148d","article-title":"Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients","volume":"21","author":"Loutfy","year":"2007","journal-title":"AIDS (London, England)"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib10","first-page":"979","article-title":"HIV-associated facial lipoatrophy","volume":"28","author":"James","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2015.08.040_bib11","unstructured":"Oxford Center for Evidence-based Medicine. Levels of evidence. Available from: URL:http:\/\/www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/. Accessed August 5, 2014."},{"issue":"12","key":"10.1016\/j.jaad.2015.08.040_bib12","first-page":"1339","article-title":"Facial volume augmentation in 2014: overview of different filler options","volume":"12","author":"Luebberding","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1468-1293.2006.00342.x","article-title":"Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy","volume":"7","author":"Moyle","year":"2006","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.040_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/QAI.0b013e318158bec9","article-title":"A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy","volume":"46","author":"Carey","year":"2007","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1293.2008.00667.x","article-title":"Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up","volume":"10","author":"Carey","year":"2009","journal-title":"HIV Med"},{"issue":"10","key":"10.1016\/j.jaad.2015.08.040_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/aid.2009.0029","article-title":"Immediate versus delayed surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy: a randomized open-label study","volume":"25","author":"Narciso","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"17","key":"10.1016\/j.jaad.2015.08.040_bib18","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS (London, England)"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.040_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000087608","article-title":"Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients","volume":"18","author":"Borelli","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy","volume":"52","author":"Burgess","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.040_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/135965350501000606","article-title":"Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study","volume":"10","author":"Guaraldi","year":"2005","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.qai.0000152834.02912.98","article-title":"Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients","volume":"38","author":"Lafaurie","year":"2005","journal-title":"J Acqui Immune Defici Syndr (1999)"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib23","first-page":"1336","article-title":"Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience","volume":"32","author":"Mest","year":"2006","journal-title":"Dermatol Surg"},{"issue":"12","key":"10.1016\/j.jaad.2015.08.040_bib24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/apc.2006.20.829","article-title":"Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances","volume":"20","author":"Negredo","year":"2006","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib25","first-page":"123","article-title":"Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging","volume":"6","author":"Hanke","year":"2007","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bodyim.2007.05.003","article-title":"Does severity predict distress? The relationship between subjective and objective measures of appearance and psychological adjustment, during treatment for facial lipoatrophy","volume":"4","author":"Ong","year":"2007","journal-title":"Body Image"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1089\/apc.2007.0029","article-title":"Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study","volume":"21","author":"Orlando","year":"2007","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/09540120701868345","article-title":"The face of HIV and AIDS: can we erase the stigma?","volume":"20","author":"Kavouni","year":"2008","journal-title":"AIDS Care"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.040_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaad.2008.07.027","article-title":"Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study","volume":"59","author":"Levy","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bjps.2007.10.031","article-title":"Experience in the treatment of HIV-associated lipodystrophy","volume":"61","author":"Nelson","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2015.08.040_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1524-4725.2008.01047.x","article-title":"Retreatment with injectable poly-L-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study","volume":"35","author":"Mest","year":"2009","journal-title":"Dermatol Surg"},{"issue":"12","key":"10.1016\/j.jaad.2015.08.040_bib32","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.bjps.2008.07.046","article-title":"Objective evidence for the use of polylactic acid implants in HIV-associated facial lipoatrophy using three-dimensional surface laser scanning and psychological assessment","volume":"62","author":"Ong","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"7 Pt 2","key":"10.1016\/j.jaad.2015.08.040_bib33","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1524-4725.2012.02474.x","article-title":"Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES)","volume":"38","author":"Bassichis","year":"2012","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.jaad.2015.08.040_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/hiv.12021","article-title":"Polylactic acid vs polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) 132 SMILE]","volume":"14","author":"Lafaurie","year":"2013","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1090820X13515270","article-title":"Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life","volume":"34","author":"van Rozelaar","year":"2014","journal-title":"Aesthet Surg J"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib36","first-page":"288","article-title":"The \u201csmile-and-fill\u201d injection technique: a dynamic approach to midface volumization","volume":"13","author":"Wang","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.040_bib37","first-page":"542","article-title":"Facial enhancement and the European experience with Sculptra (poly-L-lactic acid)","volume":"3","author":"Vleggaar","year":"2004","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib38","first-page":"1407","article-title":"Persistent granulomatous inflammatory response induced by injectable poly-L-lactic acid for HIV lipoatrophy","volume":"32","author":"Wildemore","year":"2006","journal-title":"Dermatolog Surg"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.asj.2008.06.005","article-title":"Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review","volume":"28","author":"Kates","year":"2008","journal-title":"Aesthet Surg J"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00266-008-9226-7","article-title":"Duration of correction for human immunodeficiency virus-associated lipoatrophy after retreatment with injectable poly-L-lactic acid","volume":"33","author":"Mest","year":"2009","journal-title":"Aesthet Plast Surg"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib41","first-page":"2","article-title":"Treatment of HIV-associated facial lipoatrophy with Radiance FN (Radiesse)","volume":"10","author":"Comite","year":"2004","journal-title":"Dermatol Online J"},{"issue":"3 Suppl","key":"10.1016\/j.jaad.2015.08.040_bib42","doi-asserted-by":"crossref","first-page":"34s","DOI":"10.1097\/01.prs.0000234847.36020.52","article-title":"Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability","volume":"118","author":"Silvers","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2015.08.040_bib43","first-page":"S78","article-title":"Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib44","first-page":"1486","article-title":"Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2010.12.018","article-title":"Large-particle calcium hydroxylapatite injection for correction of facial wrinkles and depressions","volume":"65","author":"Alam","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2015.08.040_bib46","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/dsu.12358","article-title":"Safety and efficacy of one-step rehabilitation of human immunodeficiency virus-related facial lipoatrophy using an injectable calcium hydroxylapatite dermal filler","volume":"39","author":"Rauso","year":"2013","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1468-1293.2009.00761.x","article-title":"Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study","volume":"11","author":"Skeie","year":"2010","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib48","first-page":"54","article-title":"Local treatment of facial lipodystrophy in patients receiving HIV protease inhibitor therapy","volume":"43","author":"Ritt","year":"2001","journal-title":"Acta Chir Plast"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00042728-200501000-00019","article-title":"Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy","volume":"31","author":"Gooderham","year":"2005","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.otohns.2006.11.049","article-title":"Injectable hyaluronic acid for the correction of HIV-associated facial lipoatrophy","volume":"136","author":"Denton","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000148252","article-title":"Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy","volume":"217","author":"Bechara","year":"2008","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00266-011-9771-3","article-title":"High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy","volume":"36","author":"Pignatti","year":"2012","journal-title":"Aesthet Plast Surg"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.040_bib53","first-page":"690","article-title":"Monophasic, cohesive-polydensified-matrix crosslinking-technology-based hyaluronic acid filler for the treatment of facial lipoatrophy in HIV-infected patients","volume":"9","author":"Pavicic","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib54","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.prs.0000298108.46379.15","article-title":"Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: a 2-year clinical experience","volume":"121","author":"de Santis","year":"2008","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00266-011-9757-1","article-title":"Polyacrylamide gel for facial wasting rehabilitation: how many milliliters per session?","volume":"36","author":"Rauso","year":"2012","journal-title":"Aesthet Plast Surg"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/aid.2008.0230","article-title":"Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy","volume":"25","author":"Negredo","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.040_bib57","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00266-011-9671-6","article-title":"Polyacrylamide gel treatment of antiretroviral therapy-induced facial lipoatrophy in HIV patients","volume":"35","author":"Mansor","year":"2011","journal-title":"Aesthet Plast Surg"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib58","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1524-4725.2011.02131.x","article-title":"Polyacrylamide gel injection for treatment of human immunodeficiency virus-associated facial lipoatrophy: 18 months follow-up","volume":"37","author":"Rauso","year":"2011","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PRS.0b013e3182362142","article-title":"Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up","volume":"129","author":"de Santis","year":"2012","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/aid.2011.0042","article-title":"Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study","volume":"28","author":"Mole","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaad.2015.08.040_bib61","doi-asserted-by":"crossref","unstructured":"Rauso R. 5-Year study of a polyacrylamide hydrogel-based filler for rehabilitation of HIV-related facial lipoatrophy. Aesthet Surg J. doi: http:\/\/dx.doi.org\/10.1093\/asj\/sjv036. Published online May 7, 2015.","DOI":"10.1093\/asj\/sjv036"},{"key":"10.1016\/j.jaad.2015.08.040_bib62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/aid.2015.0004","article-title":"Ten-year safety with polyacrylamide gel used to correct facial lipoatrophy in HIV-infected patients","volume":"31","author":"Negredo","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib63","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cid\/cis745","article-title":"Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy","volume":"55","author":"Nadarajah","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jaad.2015.08.040_bib64","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/09540120902814379","article-title":"Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy","volume":"21","author":"Antoniou","year":"2009","journal-title":"AIDS Care"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.040_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1310\/hct1206-323","article-title":"Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophy","volume":"12","author":"Loutfy","year":"2011","journal-title":"HIV Clin Trials"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.040_bib66","first-page":"804","article-title":"Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs","volume":"32","author":"Treacy","year":"2006","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000098575","article-title":"Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy","volume":"214","author":"Ramon","year":"2007","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib68","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/SCS.0b013e31811eda9c","article-title":"Cheek augmentation with Bio-Alcamid in facial lipoatrophy in HIV seropositive patients","volume":"19","author":"Honig","year":"2008","journal-title":"J Craniofac Surg"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.040_bib69","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00266-008-9189-8","article-title":"Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients","volume":"32","author":"Karim","year":"2008","journal-title":"Aesthet Plast Surg"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2015.08.040_bib70","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1524-4725.2009.01340.x","article-title":"Complications after treatment with polyalkylimide","volume":"35","author":"Schelke","year":"2009","journal-title":"Dermatol Sur"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bjps.2010.04.039","article-title":"Early and late complications of polyalkylimide gel (Bio-Alcamid)(R)","volume":"64","author":"Nelson","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"12","key":"10.1016\/j.jaad.2015.08.040_bib72","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bjps.2012.06.017","article-title":"Patient satisfaction following Bio-Alcamid injection for facial contour defects","volume":"65","author":"George","year":"2012","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clindermatol.2007.09.017","article-title":"Non-hyaluronic acid fillers","volume":"26","author":"Thioly-Bensoussan","year":"2008","journal-title":"Clin Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2015.08.040_bib74","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1524-4725.2009.01216.x","article-title":"Polymethylmethacrylate facial implant: a successful personal experience in Brazil for more than 9 years","volume":"35","author":"Carvalho Costa","year":"2009","journal-title":"Dermatol Surg"},{"issue":"10","key":"10.1016\/j.jaad.2015.08.040_bib75","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-4632.2011.04926.x","article-title":"Lipoatrophy in patients with AIDS: treatment with polymethylmethacrylate in Amazonas, Brazil","volume":"50","author":"Orsi","year":"2011","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2015.08.040_bib76","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1258\/ijsa.2009.009086","article-title":"The impact of facial lipoatrophy treatment with polymethyl methacrylate in AIDS patients as measured by four quality-of-life questionnaires","volume":"22","author":"Warde","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"8","key":"10.1016\/j.jaad.2015.08.040_bib77","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1468-3083.2012.04632.x","article-title":"An index for staging facial lipoatrophy and evaluation of the efficacy of the treatment with polymethylmethacrylate in HIV\/AIDS patients: a pilot study","volume":"27","author":"Serra","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib78","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1590\/abd1806-4841.2013895","article-title":"Treatment of HIV-associated facial lipoatrophy: impact on infection progression assessed by viral load and CD4 count","volume":"88","author":"Soares","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.040_bib79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/ijd.12400","article-title":"Treatment of facial lipoatrophy with polymethylmethacrylate among patients with human immunodeficiency virus\/acquired immunodeficiency syndrome (HIV\/AIDS): impact on the quality of life","volume":"53","author":"Quintas","year":"2014","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2015.08.040_bib80","first-page":"1279","article-title":"Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial","volume":"30","author":"Jones","year":"2004","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jaad.2013.03.025","article-title":"HIV-associated facial lipoatrophy treated with injectable silicone oil: a pilot study","volume":"69","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0094-1298(20)31069-5","article-title":"Facial recontouring with lipostructure","volume":"24","author":"Coleman","year":"1997","journal-title":"Clin Plast Surg"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib83","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.PRS.0000097288.27152.38","article-title":"Treatment of human immunodeficiency virus-associated lipodystrophy with dermafat graft transfer to the malar area","volume":"113","author":"Strauch","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.jaad.2015.08.040_bib84","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archderm.141.10.1220","article-title":"Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique","volume":"141","author":"Burnouf","year":"2005","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.040_bib85","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bjps.2005.12.047","article-title":"Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants","volume":"59","author":"Mori","year":"2006","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.040_bib86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1468-1293.2008.00682.x","article-title":"Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents","volume":"10","author":"Dollfus","year":"2009","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.040_bib87","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/SCS.0b013e31822e5cf8","article-title":"Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients","volume":"22","author":"Rauso","year":"2011","journal-title":"J Craniofac Surg"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.040_bib88","first-page":"202","article-title":"A facial marker in facial wasting rehabilitation","volume":"11","author":"Rauso","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.040_bib89","first-page":"50","article-title":"Biological properties of a new volumizing hyaluronic acid filler: a systematic review","volume":"14","author":"Ho","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.08.040_bib90","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215021106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215021106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:36:49Z","timestamp":1759271809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215021106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0190962215021106"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.08.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}